AGP Executive Report
Last update: 2 hours agoHemp Rules: Federal restrictions set for Dec. 11 would cap finished hemp products at 0.4 milligrams of total THC per container; industry estimates suggest roughly 95% of current hemp-derived products could be affected. Businesses are clearing shelves and weighing lawsuits, while advocates and lawmakers seek ways to preserve access. State Fallout: Illinois restrictions took effect Thursday, though enforcement is paused until Nov. 19 for some businesses in a federal lawsuit. A Peoria dispensary expects more customers as unlicensed retailers face limits; Missouri businesses have also pulled products and closed shops. Cannabis Standards: Massachusetts regulators are advancing testing rules that would require testing before sale and clearer labels for products that have been sanitized or remediated. CBD Research: Lab tests found cannabigerol’s anti-inflammatory effects on brain immune cells were inconsistent and dose-dependent; high concentrations damaged cells, underscoring that supplement claims need further study.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
